Provided are processes for preparing alpha, beta-unsaturated functional compounds using four major reaction steps: 1) air oxidation of an iso-paraffin to a mixture of alkyl hydroperoxide and alcohol; 2) converting the alkyl hydroperoxide and alcohol to dialkyl peroxide; 3) oxidative cross-coupling between a primary or secondary alcohol and a compound comprising at least one R3CH2- (R3=hydrogen or an optionally substituted hydrocarbyl) moiety to afford a coupled product using the dialkyl peroxide as a radical initiator, while the dialkyl peroxide is converted to a tertiary alcohol; 4) dehydration of the coupled product to yield an alpha, beta-unsaturated functional compound.

Provided are processes for preparing alpha, beta-unsaturated functional compounds using four major reaction steps: 1) air oxidation of an iso-paraffin to a mixture of alkyl hydroperoxide and alcohol; 2) converting the alkyl hydroperoxide and alcohol to dialkyl peroxide; 3) oxidative cross-coupling between a primary or secondary alcohol and a compound comprising at least one R3CH2- (R3=hydrogen or an optionally substituted hydrocarbyl) moiety to afford a coupled product using the dialkyl peroxide as a radical initiator, while the dialkyl peroxide is converted to a tertiary alcohol; 4) dehydration of the coupled product to yield an alpha, beta-unsaturated functional compound.

The present invention relates to processes for the preparation of (R)-1-(5-chloro-[1,1-biphenyl]-2-yl)-2,2,2-trifluoroethanol, 1-(5-chloro-[1,1-biphenyl]-2-yl)-2,2,2-trifluoroethanone, and intermediates thereof, which are useful in the preparation of inhibitors of TPH1 for the treatment of, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, low bone mass diseases, serotonin syndrome, and cancer.

The present invention relates to processes for the preparation of (R)-1-(5-chloro-[1,1-biphenyl]-2-yl)-2,2,2-trifluoroethanol, 1-(5-chloro-[1,1-biphenyl]-2-yl)-2,2,2-trifluoroethanone, and intermediates thereof, which are useful in the preparation of inhibitors of TPH1 for the treatment of, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, low bone mass diseases, serotonin syndrome, and cancer.

The present invention relates to processes for the preparation of (R)-1-(5-chloro-[1,1-biphenyl]-2-yl)-2,2,2-trifluoroethanol, 1-(5-chloro-[1,1-biphenyl]-2-yl)-2,2,2-trifluoroethanone, and intermediates thereof, which are useful in the preparation of inhibitors of TPH1 for the treatment of, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, low bone mass diseases, serotonin syndrome, and cancer.

A method of producing a catalyst can include heating a hydrotalcite above a decomposition temperature, forming a decomposed hydrotalcite in response to the heating, combining the decomposed hydrotalcite with a metal salt to form a catalyst mixture, and heating the catalyst mixture to convert the metal salt to a metal oxide. The resulting metal oxide combined with the decomposed hydrotalcite forms the catalyst.

A method of producing a catalyst can include heating a hydrotalcite above a decomposition temperature, forming a decomposed hydrotalcite in response to the heating, combining the decomposed hydrotalcite with a metal salt to form a catalyst mixture, and heating the catalyst mixture to convert the metal salt to a metal oxide. The resulting metal oxide combined with the decomposed hydrotalcite forms the catalyst.

A method of producing a catalyst can include heating a hydrotalcite above a decomposition temperature, forming a decomposed hydrotalcite in response to the heating, combining the decomposed hydrotalcite with a metal salt to form a catalyst mixture, and heating the catalyst mixture to convert the metal salt to a metal oxide. The resulting metal oxide combined with the decomposed hydrotalcite forms the catalyst.

The invention discloses a method for preparation of alkylated, fluoro alkylated, chloro alkylated and fluorochloro alkylated compounds by a heterogeneous Co-catalysed alkylation or fluoro, chloro and fluorochloro alkylation with alkyl halides, fluoro alkyl halides, chloro alkyl halides or fluorochloro alkyl halides respectively.

The invention discloses a method for preparation of alkylated, fluoro alkylated, chloro alkylated and fluorochloro alkylated compounds by a heterogeneous Co-catalysed alkylation or fluoro, chloro and fluorochloro alkylation with alkyl halides, fluoro alkyl halides, chloro alkyl halides or fluorochloro alkyl halides respectively.